Clearside Biomedical Inc (NAS:CLSD)
$ 1.305 -0.005 (-0.38%) Market Cap: 97.54 Mil Enterprise Value: 69.42 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Clearside Biomedical Inc at JMP Securities Life Sciences Virtual Conference Transcript

Jun 16, 2021 / 05:00PM GMT
Release Date Price: $4.08 (-1.92%)
Jon Wolleben
JMP Securities LLC - Analyst

Hi. Good afternoon, everybody. Jon Wolleben here; I'm a Senior Analyst at JMP Securities and want to welcome you to our annual life sciences conference. We're pleased to have the senior management team at Clearside Biomedical here to give us an update on their progress and their development programs. We have President, CEO George Lasezkay; and Chief Medical Officer and Chief Development Officer, Tom Ciulla, on the line. So, thanks for joining us today, guys.

George Lasezkay
Clearside Biomedical, Inc. - President and CEO

Great to be here. Thanks, Jon.

Tom Ciulla
Clearside Biomedical, Inc. - Chief Medical Officer and Chief Development Officer

Thanks for having us.

Jon Wolleben
JMP Securities LLC - Analyst

I think a great place to start for those not as familiar with the Clearside story, George, would maybe do an overview on the Company and what you're working on. And then, we can dig into some more details after that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot